{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03102268",
      "OrgStudyIdInfo": {
        "OrgStudyId": "EXO-CN-1607"
      },
      "Organization": {
        "OrgFullName": "The Second Hospital of Nanjing Medical University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "ncRNAs in Exosomes of Cholangiocarcinoma",
      "OfficialTitle": "Exosomes-derived ncRNAs As Biomarkers In Cholangiocarcinoma Patients"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2017",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "May 1, 2017",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "March 31, 2020",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "March 31, 2020",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "March 8, 2017",
      "StudyFirstSubmitQCDate": "March 30, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 5, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "March 30, 2017",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "April 5, 2017",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "The Second Hospital of Nanjing Medical University",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Exosomes are part of extracellular vesicles(EVs), and can be secreted into the environment by many types of cells. It has been demonstrated that the content and function of exosomes depends on the originating cell and the conditions under which they are produced.Exosomes contain proteins,RNAs and lipid,which may transfer biological information and activities from donor cells to receptor cells. Non-coding RNAs are involved in many biological activities including tumor growth and metastasis.\n\nIn this prospective translational study, preclinical and clinical phases have been designed. On the first step, the main goal is to characterize the ncRNAs of cholangiocarcinoma derived exosomes. This exosome biomarker may provide a useful diagnostic tool. As a second step, the study will evaluate the prognostic and predictive value of cholangiocarcinoma exosomes levels in plasma in a prospectively recruited cohort of cholangiocarcinoma patients before and after surgical resection."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Cholangiocarcinoma",
          "Benign Biliary Stricture"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Observational",
      "PatientRegistry": "Yes",
      "TargetDuration": "3 Years",
      "DesignInfo": {
        "DesignObservationalModelList": {
          "DesignObservationalModel": [
            "Cohort"
          ]
        },
        "DesignTimePerspectiveList": {
          "DesignTimePerspective": [
            "Prospective"
          ]
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "80",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "cholangiocarcinoma patients",
            "ArmGroupDescription": "cholangiocarcinoma patients without any anti-cancer therapy"
          },
          {
            "ArmGroupLabel": "benign biliary stricture patients",
            "ArmGroupDescription": "benign biliary stricture patients without any therapy targeting the stricture"
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Characterization of the ncRNAs",
            "PrimaryOutcomeDescription": "Characterization of the ncRNAs in tumor derived exosomes from cholangiocarcinoma patients before anti-cancer therapies and benign biliary stricture patients",
            "PrimaryOutcomeTimeFrame": "Up to 3 years from start of study"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Overall survival",
            "SecondaryOutcomeDescription": "Correlation of exosomes-derived ncRNAs(at baseline and monthly during therapy until death) and time-to-event end-points",
            "SecondaryOutcomeTimeFrame": "Up to 3 years from start of the study"
          },
          {
            "SecondaryOutcomeMeasure": "Progression-free survival",
            "SecondaryOutcomeDescription": "Correlation of exosomes-derived ncRNAs(at baseline and monthly during therapy until tumor progression) and time-to-event end-points",
            "SecondaryOutcomeTimeFrame": "Up to 3 years from start of the study"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\n1.Provide signed informed consent. The subject is capable of understanding and complying with parameters as outlined in the protocol and able to sign informed consent, approved by the Independent Ethic Committee (IEC)/Institutional Review Board (IRB) prior to the initiation of any study-specific procedures.\n\n2.Men or women aged >= 18 years. 3.Histology- or imaging-confirmed bile duct stricture. 4.Metastatic disease or locally advanced disease not amenable to curative surgery.\n\n5.Radiographically assessable, non-measurable disease or measurable disease as per RECIST criteria.\n\n6.Life expectancy of at least 8 weeks from the time of enrollment. 7.No other malignancy within the past 5 years. 8.No prior chemotherapy for advanced disease.\n\nExclusion Criteria:\n\n- 1.Pregnant or lactating females. 2.Significant neurological or psychiatric disorders (psychotic disorders, dementia or seizures) that would prohibit the understanding and giving of informed consent.\n\n3.Active Hepatitis B or C or history of an HIV infection. 4.Active uncontrolled infection.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      },
      "StudyPopulation": "Subjects will be adults with cholangiocarcinoma and benign biliary stricture, candidates to receive a first-line systemic therapy, who meet all of the inclusion criteria and none of the exclusion criteria within 28 days prior to the first day of study treatment.",
      "SamplingMethod": "Non-Probability Sample"
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Lin Miao, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "086-25-58509932",
            "CentralContactEMail": "miaolinxh@163.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Lin Miao, MD",
            "OverallOfficialAffiliation": "Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University",
            "LocationStatus": "Recruiting",
            "LocationCity": "Nanjing",
            "LocationState": "Jiangsu",
            "LocationZip": "210011",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Lin Miao, MD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "086-25-58509932",
                  "LocationContactEMail": "miaolinxh@163.com"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "33257140",
            "ReferenceType": "derived",
            "ReferenceCitation": "Ge X, Tang L, Wang Y, Wang N, Zhou J, Deng X, Zhong Y, Li Q, Wang F, Jiang G, Miao L. The diagnostic value of exosomal miRNAs in human bile of malignant biliary obstructions. Dig Liver Dis. 2021 Jun;53(6):760-765. doi: 10.1016/j.dld.2020.11.010. Epub 2020 Nov 27."
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000018281",
            "ConditionMeshTerm": "Cholangiocarcinoma"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000000230",
            "ConditionAncestorTerm": "Adenocarcinoma"
          },
          {
            "ConditionAncestorId": "D000002277",
            "ConditionAncestorTerm": "Carcinoma"
          },
          {
            "ConditionAncestorId": "D000009375",
            "ConditionAncestorTerm": "Neoplasms, Glandular and Epithelial"
          },
          {
            "ConditionAncestorId": "D000009370",
            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
          },
          {
            "ConditionAncestorId": "D000009369",
            "ConditionAncestorTerm": "Neoplasms"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M5627",
            "ConditionBrowseLeafName": "Constriction, Pathologic",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M19578",
            "ConditionBrowseLeafName": "Cholangiocarcinoma",
            "ConditionBrowseLeafAsFound": "Cholangiocarcinoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M2737",
            "ConditionBrowseLeafName": "Adenocarcinoma",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4686",
            "ConditionBrowseLeafName": "Carcinoma",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11472",
            "ConditionBrowseLeafName": "Neoplasms, Glandular and Epithelial",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11467",
            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T755",
            "ConditionBrowseLeafName": "Bile Duct Cancer",
            "ConditionBrowseLeafAsFound": "Cholangiocarcinoma",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}